You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1805477 |
---|---|
Category | Antibodies |
Description | Anti-Nectin-4 Reference Antibodyd antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer. |
Clonality | Monoclonal |
Tested applications | ELISA, FA, FACS, Kinetics |
Reactivity | Human |
Isotype | IgG |
Purity | > 95% |
Conjugation | Unconjugated |
MW | 145.44 kDa |
Target | Nectin-4 |
Endotoxins | < 1 EU/mg |
Storage | -80°C |
Buffer/Preservatives | 100 mM Pro-Ac 20 mM Arg pH 5.0 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)is more than 100% ;determined by SEC-HPLC.
Immobilized human NECTIN 4 His at 2 μg/mL can bind Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv);EC50=0.003846μg/mL.
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human, Mouse | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human, Monkey, Mouse | |
Monoclonal | |
MMAE |
Filter by Rating